LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review
Open Access
- 24 October 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1649759
Abstract
Atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease and cerebrovascular disease, is caused by the accumulation of plaque on artery walls. Elevated levels of low-density lipoprotein (LDL) cholesterol significantly contribute to the development and progression of ASCVD. Multiple studies have provided evidence of a correlation between individual LDL subpopulations and the development of atherosclerosis (AS); among these, small, dense low-density lipoprotein (sdLDL) and lipoprotein(a) [Lp(a)] have been particularly implicated. There are multiple considerations of why sdLDL may cause AS including their low affinity for the LDL receptor, their ability to diffuse into the artery wall and remain there for a long time, and their tendency to become excessively oxidized. Oxidized LDL (oxLDL), generated under oxidative stress, drives AS by impairing endothelial function, promoting foam cell formation, and triggering vascular inflammation. Lp(a) contributes to the development and progression of AS by causing inflammation of the arterial wall. Studies conducted in recent years have found that electronegative LDL [L5/LDL(-)] may also be an important factor in the development and progression of AS. L5/LDL(-) causes atherosclerotic changes in the vascular wall by triggering apoptosis in endothelial cells via the lectin-like oxLDL receptor-1. This article offers an updated overview of ASCVD and briefly examines the classifications of atherogenic LDL subfractions and their roles in atherogenesis.Keywords
This publication has 183 references indexed in Scilit:
- Precipitated sdLDL: An easy method to estimate LDL particle sizeJournal of Clinical Laboratory Analysis, 2020
- Lipid-Related Markers and Cardiovascular Disease PredictionJAMA, 2012
- Electronegative low-density lipoprotein induces cardiomyocyte apoptosis indirectly through endothelial cell-released chemokinesApoptosis, 2012
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic ChallengesCurrent Atherosclerosis Reports, 2011
- Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary InterventionLipids, 2010
- Oxidized Low-Density Lipoprotein2009
- Low‐density lipoproteins are more electronegatively charged in type 1 than in type 2 diabetes mellitusLipids, 2006
- Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopyClinical Cardiology, 1999
- Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic controlDiabetologia, 1996
- Naturally Occurring Modified Low Density Lipoproteins Are Similar if Not Identical: More Electronegative and Desialylated Lipoprotein SubfractionsExperimental and Molecular Pathology, 1995